These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 16862806

  • 21. The evaluation of the amebicidal activity of Eryngium planum extracts.
    Derda M, Thiem B, Budzianowski J, Wojt WJ, Wojtkowiak-Giera A.
    Acta Pol Pharm; 2013; 70(6):1027-34. PubMed ID: 24383326
    [Abstract] [Full Text] [Related]

  • 22. Animal model Balamuthia mandrillaris CNS infection: contrast and comparison in immunodeficient and immunocompetent mice: a murine model of "granulomatous" amebic encephalitis.
    Janitschke K, Martínez AJ, Visvesvara GS, Schuster F.
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):815-21. PubMed ID: 8965096
    [Abstract] [Full Text] [Related]

  • 23. In vitro evaluation of the amebicidal activity of Buddleia cordata (Loganiaceae, H.B.K.) on several strains of Acanthamoeba.
    Rodríguez-Zaragoza S, Ordaz C, Avila G, Muñoz JL, Arciniegas A, Romo de Vivar A.
    J Ethnopharmacol; 1999 Sep; 66(3):327-34. PubMed ID: 10473180
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
    Martín-Pérez T, Lozano-Cruz T, Criado-Fornelio A, Ortega P, Gómez R, de la Mata FJ, Pérez-Serrano J.
    Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
    [Abstract] [Full Text] [Related]

  • 25. Bioassay guided isolation and identification of anti-Acanthamoeba compounds from Tunisian olive leaf extracts.
    Sifaoui I, López-Arencibia A, Ticona JC, Martín-Navarro CM, Reyes-Batlle M, Mejri M, Lorenzo-Morales J, Jiménez AI, Valladares B, Lopez-Bazzocchi I, Abderabba M, Piñero JE.
    Exp Parasitol; 2014 Nov; 145 Suppl():S111-4. PubMed ID: 24726697
    [Abstract] [Full Text] [Related]

  • 26. [Amebic meningoencephalitis].
    Fukuma T.
    Brain Nerve; 2009 Feb; 61(2):115-21. PubMed ID: 19235460
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro evaluation of the amebicidal activity of Pterocaulon polystachyum (Asteraceae) against trophozoites of Acanthamoeba castellanii.
    Ródio C, da Rocha Vianna D, Kowalski KP, Panatieri LF, von Poser G, Rott MB.
    Parasitol Res; 2008 Dec; 104(1):191-4. PubMed ID: 18795331
    [Abstract] [Full Text] [Related]

  • 29. Antimicrobial effect of auranofin against Acanthamoeba spp.
    Loufouma Mbouaka A, Leitsch D, Koehsler M, Walochnik J.
    Int J Antimicrob Agents; 2021 Nov; 58(5):106425. PubMed ID: 34419578
    [Abstract] [Full Text] [Related]

  • 30. Granulomatous amebic encephalitis: an under-recognized cause of infectious mortality after hematopoietic stem cell transplantation.
    Akpek G, Uslu A, Huebner T, Taner A, Rapoport AP, Gojo I, Akpolat YT, Ioffe O, Kleinberg M, Baer MR.
    Transpl Infect Dis; 2011 Aug; 13(4):366-73. PubMed ID: 21338461
    [Abstract] [Full Text] [Related]

  • 31. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
    Visvesvara GS, Moura H, Schuster FL.
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):1-26. PubMed ID: 17428307
    [Abstract] [Full Text] [Related]

  • 32. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.
    Cabello-Vílchez AM, Martín-Navarro CM, López-Arencibia A, Reyes-Batlle M, Sifaoui I, Valladares B, Piñero JE, Lorenzo-Morales J.
    Parasitol Res; 2014 Feb; 113(2):755-9. PubMed ID: 24265059
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
    Hernández-Martínez D, Reyes-Batlle M, Castelan-Ramírez I, Hernández-Olmos P, Vanzzini-Zago V, Ramírez-Flores E, Sifaoui I, Piñero JE, Lorenzo-Morales J, Omaña-Molina M.
    Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Disseminated cutaneous acanthamebiasis: a case report and review of the literature.
    Paltiel M, Powell E, Lynch J, Baranowski B, Martins C.
    Cutis; 2004 Apr; 73(4):241-8. PubMed ID: 15134324
    [Abstract] [Full Text] [Related]

  • 36. Cutaneous Acanthamoeba infection in the acquired immunodeficiency syndrome: response to multidrug therapy.
    Hunt SJ, Reed SL, Mathews WC, Torian B.
    Cutis; 1995 Nov; 56(5):285-7. PubMed ID: 8565615
    [Abstract] [Full Text] [Related]

  • 37. In vitro amoebicidal activity of Origanum syriacum and Origanum laevigatum on Acanthamoeba castellanii cysts and trophozoites.
    Degerli S, Tepe B, Celiksoz A, Berk S, Malatyali E.
    Exp Parasitol; 2012 May; 131(1):20-4. PubMed ID: 22417972
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood-brain barrier.
    Alsam S, Sissons J, Jayasekera S, Khan NA.
    J Infect; 2005 Aug; 51(2):150-6. PubMed ID: 16038767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.